Future research may focus on clinical applications, exploring its pharmacokinetics, long-term safety, and synergistic effects with existing therapeutic approaches and higher experimental models, paving the way for SHLP6 to become a valuable tool in managing neurodegenerative diseases and oxidative stress-related conditions. Here, MT-RNR2 is linked to neurodegenerative disease.